Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 692 of 1,261
  1. US 9351989

    Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections

    University College Cardiff Consultants Limited · Granted May 31, 2016 · Expires May 26, 2036

    granted
  2. US 9351975

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  3. US 9351997

    Method of treating cancer

    Intensity Therapeutics, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  4. US 9351968

    Methods of treating developmental disorders using pipradrol

    OVID THERAPEUTICS INC. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  5. US 9351960

    Agent for the treatment of viral hepatitis C

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted May 31, 2016 · Expires May 26, 2036

    granted
  6. PH 12016500580

    CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER

    OXFORD BIOTHERAPEUTICS LTD [GB] · Granted May 30, 2016 · Expires May 25, 2036

    granted
  7. US 9346746

    R(+)-N-formyl-propargyl-aminoindan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 24, 2016 · Expires May 19, 2036

    granted
  8. US 9346829

    5-HT3 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted May 24, 2016 · Expires May 19, 2036

    granted
  9. US 9345758

    Materials and methods for respiratory disease control in canines

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted May 24, 2016 · Expires May 19, 2036

    granted
  10. US 9345726

    CD117+ cells and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted May 24, 2016 · Expires May 19, 2036

    granted
  11. US 9345708

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted May 24, 2016 · Expires May 19, 2036

    granted
  12. US 9345780

    Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

    Tekmira Pharmaceuticals Corporation · Granted May 24, 2016 · Expires May 19, 2036

    granted
  13. US 9347951

    Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted May 24, 2016 · Expires May 19, 2036

    granted
  14. US 9346875

    Therapy for filovirus infection

    The United States of America as represented by the Secretary of the Army · Granted May 24, 2016 · Expires May 19, 2036

    granted
  15. US 9347054

    Polymer factor IX moiety conjugates

    Nektar Therapeutics · Granted May 24, 2016 · Expires May 19, 2036

    granted
  16. US 9347143

    Membrane template synthesis of microtube engines

    The Regents of the University of California · Granted May 24, 2016 · Expires May 19, 2036

    granted
  17. US 9347063

    Oligonucleotide analog and method for treating flavivirus infections

    Sarepta Therapeutics, Inc. · Granted May 24, 2016 · Expires May 19, 2036

    granted
  18. US 9347062

    Interfering RNA delivery system and uses thereof

    Arrowhead Research Corporation · Granted May 24, 2016 · Expires May 19, 2036

    granted
  19. US 9346880

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted May 24, 2016 · Expires May 19, 2036

    granted
  20. US 9346917

    Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics · Granted May 24, 2016 · Expires May 19, 2036

    granted
  21. US 9346865

    Antimicrobial peptides and methods of use

    The Regents of the University of Colorado, a Body Corporate · Granted May 24, 2016 · Expires May 19, 2036

    granted
  22. US 9346867

    Cancer-related glycopeptide epitopes, antibodies and methods of use

    SUMITOMO BAKELITE CO., LTD. · Granted May 24, 2016 · Expires May 19, 2036

    granted
  23. US 9346866

    Inhibition of tace activity with cyclic peptides

    The Regents of the University of California · Granted May 24, 2016 · Expires May 19, 2036

    granted
  24. US 9346859

    Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2016 · Expires May 19, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.